stockrowCumberland Pharmaceuticals Inc. (CPIX) vs SCYNEXIS, Inc. (SCYX)
- Cumberland Pharmaceuticals Inc. CPIX 5.18 +3.39%
- SCYNEXIS, Inc. SCYX 3.52 +6.67%
Cumberland Pharmaceuticals Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. is the larger, with a market value of $75.1M against $32.8M — 2.3× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −25.7%. Cumberland Pharmaceuticals Inc. has the higher net margin (−34.9% vs −49.7%) and the higher return on invested capital (−34.2% vs −110.7%). Across the 17 metrics below, SCYNEXIS, Inc. leads on 9 and Cumberland Pharmaceuticals Inc. on 8.
Valuation
Profitability
| Metric | CPIX | SCYX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 110.49% | 100.00% | 53.51% |
| Operating margin | (23.20%) | (109.90%) | 0.00% |
| Net margin | (34.92%) | (49.74%) | (2.45%) |
| Free cash flow margin | 1.84% | (64.67%) | 0.00% |
| Return on equity | (48.76%) | (18.38%) | (0.80%) |
| Return on assets | (16.70%) | (15.09%) | (1.67%) |
| Return on invested capital | (34.23%) | (110.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack